Ozempic vs. Wegovy: The Real Difference and the Real Price

Ozempic or Wegovy: which one should you pick?

Your diagnosis and how you pay decide this, more than the drug itself. Here is the short answer for each situation.

• You have type 2 diabetes: Ozempic is the on-label choice. Your insurance and its $25 savings card are built for it.
• Weight loss is the goal, and your plan covers weight management: Wegovy with its savings card can cost as little as $25 a fill. Ozempic's card needs a diabetes prescription.
• You're on Medicare: the GLP-1 Bridge charges $50 a month for Wegovy if you qualify. Ozempic isn't part of it.
• You pay cash and want the brand-name drug: buy Wegovy through NovoCare, Novo Nordisk's own cash-pay program. It costs the same as Ozempic or less.
• Lowest cash price: the Wegovy pill starts at about $150 a month. Compounded semaglutide starts near that and costs less at higher doses, but it isn't FDA-approved.
• Needles are a hard no: both brands now come as a daily pill. See Wegovy pills and patches.

What's actually different between Ozempic and Wegovy?

Search either name and the other one pops up, for good reason. Both are semaglutide, made by the same company, Novo Nordisk. Semaglutide is a GLP-1 drug. It copies a gut hormone that lowers blood sugar and appetite. Think of Ozempic and Wegovy as two editions of one product, sold under two names for different uses.

Three things truly separate them. Your price, your insurance and the savings card all follow from these three.

• FDA-approved use: Ozempic is approved for adults with type 2 diabetes. Wegovy is approved for weight management. It is also approved to lower heart risk in adults with heart disease and excess weight. Since 2025, it also treats a fatty liver disease called MASH.
• Dose ceiling: Ozempic tops out at 2 mg a week. Wegovy's standard top dose is 2.4 mg. A newer high dose, Wegovy HD, reaches 7.2 mg.
• What follows the label: insurers, savings cards and Medicare treat them as two different products. That holds even though the pen, or the pill, holds the same medicine.

Which one am I supposed to get, for diabetes or weight loss?

Your diagnosis decides before your preference does. With type 2 diabetes, Ozempic is the on-label choice. It's the one your insurance is built to cover.

For weight management, Wegovy carries the FDA approval. It's for adults with a BMI, or body mass index, of 30 or more. It's also for a BMI of 27 or more with a weight-related condition, like high blood pressure or sleep apnea.

Both brands now come as a daily pill too. The Ozempic pill, sold since May 2026, is for type 2 diabetes. It is a newer tablet that replaces Rybelsus, and its doses don't match Rybelsus mg for mg. Ozempic vs. Rybelsus covers that change. The Wegovy pill reached US pharmacies in January 2026. It was the first GLP-1 pill approved for weight loss. If needles are the real obstacle, Wegovy pills and patches compares the pill to the shot.

A prescriber can also write either drug off-label. That means for a use the label doesn't list. Ozempic for weight loss without diabetes is the common case. It's legal, but it doesn't change how your insurer reads the prescription.

Does Wegovy work better for weight loss than Ozempic?

The two brands are the same drug, so the real comparison is dose against dose. In the STEP 1 trial, adults on Wegovy's 2.4 mg dose lost close to 15% of their body weight over 68 weeks. People on a placebo, a dummy shot, lost about 2%. In the STEP UP trial, the 7.2 mg dose led to more weight loss on average than 2.4 mg.

Ozempic stops at 2 mg, below Wegovy's standard dose. So Wegovy isn't a stronger drug. It's the same drug, dosed at the level the weight-loss trials tested.

Which costs less, Ozempic or Wegovy?

For most women without diabetes, Wegovy costs the same or less. The table above shows every route. Here is what sits behind the numbers.

Brand self-pay, no insurance

NovoCare is Novo Nordisk's own cash-pay program. It sells both drugs at nearly matching prices. You can get them by home delivery, or at a local pharmacy with the savings offer.

• Ozempic pill or Wegovy pill: about $150 a month at the starting dose · About $200 at 4 mg · About $300 at the top doses
• Wegovy pen: about $350 a month · About $400 at the 7.2 mg dose · New patients: first 2 fills about $200 at the starting doses, through Dec 31, 2026
• Ozempic pen: about $350 a month up to 1 mg · About $500 at 2 mg · New patients: first 2 fills about $200 at the starting doses, through Dec 31, 2026

NovoCare says it will update Ozempic's self-pay prices after December 31, 2026.

List prices are the prices before any discount, and they differ more. Ozempic lists at about $1,000 a month. Wegovy lists at about $1,350. Almost no one pays either, because NovoCare charges far less. Novo Nordisk says both list prices drop to $675 on January 1, 2027.

With insurance and the savings card

This is where the label really shows. Both savings cards can bring a fill down to as little as $25. Each card takes off at most $100 a month. Neither works with Medicare, Medicaid or other government plans.

The rules differ on diagnosis. Ozempic's card needs a plan that covers Ozempic and a type 2 diabetes prescription. A chart that says only "weight loss" doesn't qualify. Wegovy's card needs a plan that covers Wegovy for weight management, so no diabetes is required.

If your plan doesn't cover Wegovy, its card still gets you the self-pay price at a regular pharmacy. So a woman using semaglutide for weight loss has a real shot at Wegovy's $25 price. She has almost none at Ozempic's.

On Medicare

Medicare's GLP-1 Bridge charges $50 a month for Wegovy, pen or pill. It runs from July 2026 through December 2027. You need to meet its BMI and health rules. Ozempic isn't part of it.

People with type 2 diabetes can't use the Bridge. Medicare says their regular Part D drug plan should cover a GLP-1 for diabetes instead. Part D won't cover Ozempic for weight loss alone.

Compounded semaglutide

Compounded semaglutide is mixed by a pharmacy, not made by Novo Nordisk. It isn't FDA-approved Ozempic or Wegovy, and it isn't sold under either name. Since the semaglutide shortage ended in February 2025, the FDA allows compounding only in narrower cases.

• Mochi Health: about $140 a month at the lowest dose, $79 membership included · About $270 at the top dose · First month about $60, not in every state
• Fridays: about $280 a month, month to month · About $150 a month with a year paid upfront · Coaching included

Compounded semaglutide costs less than either brand-name pen. Against the Wegovy pill, it's closer. The pill starts at about $150, like the cheapest compounded plans. At its top doses, the pill costs about $300, more than most compounded plans.

Can my doctor just prescribe Ozempic instead of Wegovy to save money?

Yes, it's legal, but in 2026 it rarely saves money. NovoCare prices the Ozempic pen the same as Wegovy's up to 1 mg. At 2 mg, the Ozempic pen costs more. The two pills cost the same. So if you pay cash, off-label Ozempic doesn't beat Wegovy.

It also costs you options. Ozempic's $25 card needs a type 2 diabetes prescription. Insurers often deny Ozempic when weight is the only diagnosis. Medicare's Bridge covers Wegovy, not Ozempic. Without diabetes, price out Wegovy first.

Can you switch between Ozempic and Wegovy?

Yes, and it's a routine change. The pens hold the same medicine, so there's no tricky dose conversion. Prescribers switch patients for a few common reasons.

• The insurer's drug list changes and starts favoring one brand.
• The diagnosis changes, as when prediabetes becomes type 2 diabetes.
• Weight loss stalls on off-label Ozempic, and Wegovy's higher doses give more room.

Your prescriber picks the dose step on the new brand.

How do Ozempic and Wegovy compare with Mounjaro and Zepbound?

Mounjaro and Zepbound are a different medicine, tirzepatide, made by Eli Lilly. They follow the same split: Mounjaro for type 2 diabetes, Zepbound for weight management. In the SURMOUNT-5 trial, tirzepatide led to more weight loss on average than semaglutide. Each drug was given at the highest dose people could tolerate.

Mounjaro vs. Ozempic, Wegovy vs. Mounjaro, Wegovy vs. Zepbound and Ozempic vs. Zepbound cover those matchups and their prices.

Are the side effects different between Ozempic and Wegovy?

Not in kind. Both cause the same stomach side effects. Nausea, vomiting, diarrhea and constipation are the most common. They are usually worst in the weeks after a dose increase.

What can differ is how strong they feel, and that follows the dose more than the brand. In the STEP UP trial, stomach side effects were more common at 7.2 mg than at 2.4 mg. That's a reason to step up slowly on either brand. It doesn't make one name gentler than the other. Ozempic side effects and Wegovy side effects go into detail.

Does either make more sense for perimenopause or menopause weight gain?

Midlife weight gain has a hormonal side. Falling estrogen tends to shift fat toward the belly. It also makes the body handle sugar less well.

Ozempic and Wegovy act on this the same way, because they are the same medicine. They help the body release insulin when blood sugar rises. They also quiet appetite.

If weight, not blood sugar, is your main goal, Wegovy's higher doses give it more room to work. There is no menopause-specific winner between the two brands. The useful question is which label fits your diagnosis, your insurance and your budget.